Stroke prevention in atrial fibrillation: Past, present and future
- 1 July 2017
- journal article
- research article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 117 (07), 1230-1239
- https://doi.org/10.1160/th16-11-0876
Abstract
Thrombosis and Haemostasis publishes original basic research and clinical studies in vascular biology and medicine, serving as an international platform for dissemination and debate of scientific information at the cutting edge.This publication has 84 references indexed in Scilit:
- Adherence to oral anticoagulant therapy in patients with atrial fibrillationThrombosis and Haemostasis, 2017
- Therapy persistence in newly diagnosed non-valvular atrial fibrillation treated with warfarin or NOACThrombosis and Haemostasis, 2016
- Asymptomatic Atrial FibrillationJAMA, 2015
- A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conferenceEP Europace, 2015
- Vitamin K antagonists in heart disease: Current status and perspectives (Section III)Thrombosis and Haemostasis, 2013
- Validation of the CHADS2 clinical prediction rule to predict ischaemic strokeThrombosis and Haemostasis, 2011
- The CHADS2 score for stroke risk stratification in atrial fibrillation – friend or foe?Thrombosis and Haemostasis, 2010
- Adjusted-Dose Warfarin versus Aspirin for Preventing Stroke in Patients with Atrial FibrillationAnnals of Internal Medicine, 2007
- Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial FibrillationAnnals of Internal Medicine, 2007
- Echocardiographic Predictors of Stroke in Patients With Atrial FibrillationArchives of Internal Medicine, 1998